Open access peer-reviewed Edited Volume

Advancements in Tumor Immunotherapy and Cancer Vaccines

Edited by Hilal Arnouk

Midwestern University

Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical researchers have joined forces to collaborate and review current developments and trends in cancer immunology for the purposes of this book, and the result is a promising review of contemporary clinical treatments. In each chapter the authors present the scientific basis behind such therapeutic approaches, including cancer vaccines with special focus on prostate cancer, melanoma and novel approaches utilizing both innate and adaptive immune responses.

Read more >Order hardcopy
IntechOpen
Advancements in Tumor Immunotherapy and Cancer VaccinesEdited by Hilal Arnouk

Published: February 3rd 2012

DOI: 10.5772/1453

ISBN: 978-953-307-998-1

Copyright year: 2012

Books open for chapter submissions

18480 Total Chapter Downloads

2 Crossref Citations

1 Web of Science Citations

7 Dimensions Citations

chaptersDownloads

Open access peer-reviewed

1. Immunotherapy in Urologic Malignancies: The Evolution and Future of Pattern Recognition Receptors

By Jane Lee and Arnold I. Chin

1260

Open access peer-reviewed

2. Vaccine and Cancer Therapy for Genitourinary Tumors

By Robert J. Amato and Mika Stepankiw

1336

Open access peer-reviewed

3. Challenges to Prostate Cancer Immunotherapy

By Elena N. Klyushnenkova and Richard B. Alexander

1529

Open access peer-reviewed

4. Prostate Cancer Immunotherapy – Strategy with a Synthetic GnRH Based Vaccine Candidate

By J.A. Junco, F. Fuentes, R. Basulto, E. Bover, M.D. Castro, E. Pimentel, O. Reyes, R. Bringas, L. Calzada, Y. López, N. Arteaga, A. Rodríguez, H. Garay, R. Rodríguez, L. González-Quiza, L. Fong and G.E. Guillén

2023

Open access peer-reviewed

5. Immune-Therapy in Cutaneous Melanoma – Efficacy Immune Markers

By Monica Neagu and Carolina Constantin

1557

Open access peer-reviewed

6. Innate Immunity-Based Immunotherapy of Cancer

By Kouji Maruyama, Hidee Ishii, Sachiko Tai, Jinyan Cheng, Takatomo Satoh, Sachiko Karaki, Shingo Akimoto and Ken Yamaguchi

1724

Open access peer-reviewed

7. The Potential Use of Triterpene Compounds in Dendritic Cells-Based Immunotherapy

By Masao Takei, Akemi Umeyama and Je-Jung Lee

1238

Open access peer-reviewed

8. The Novel Use of Zwitterionic Bacterial Components and Polysaccharides in Immunotherapy of Cancer and Immunosuppressed Cancer Patients

By A.S. Abdulamir, R.R. Hafidh and F. Abubaker

1716

Open access peer-reviewed

9. Type III Interferons IL-28 and IL-29: Novel Interferon Family Members with Therapeutic Potential in Cancer Therapy

By Hitomi Fujie and Muneo Numasaki

2580

Open access peer-reviewed

10. Interleukin 12: Stumbling Blocks and Stepping Stones to Effective Anti-Tumor Therapy

By Hollie J. Pegram, Alena A. Chekmasova, Gavin H. Imperato and Renier J. Brentjens

3517

Edited Volume and chapters are indexed in

  • Worldcat
  • OpenAIRE
  • Google Scholar
  • AZ ebsco
  • Base
  • CNKI

Order a hardcopy of the Edited Volume

Free shipping with DHL Express

Hardcover (ex. VAT)£140

Order now

Residents of European Union countries need to add a Book Value-Added Tax of 5%. Institutions and companies, registered as VAT taxable entities in their own EU member state, will not pay VAT by providing IntechOpen with their VAT registration number. This is made possible by the EU reverse charge method.

Special discount for IntechOpen contributors

All IntechOpen contributors are offered special discounts starting at 40% OFF available through your personal dashboard

Login and purchase